๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain : High rate of thromboembolic events (CALGB 500102)

โœ Scribed by Susan E. Krown; Donna Niedzwiecki; Wen-Jen Hwu; Lydia Hodgson; Alan N. Houghton; Frank G. Haluska; for the Cancer; Leukemia Group B

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
108 KB
Volume
107
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A high rate of venous thromboembolism in
A high rate of venous thromboembolism in a multi-institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma
โœ Apurva A. Desai; Nicholas J. Vogelzang; Brian I. Rini; Rafat Ansari; Stuart Krau ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND The objective of this study was to determine the clinical response rate of the combination of weekly intravenous (IV) gemcitabine with continuous infusion fluorouracil (5โ€FU) and daily oral thalidomide in patients with metastatic renal cell carcinoma (RCC). ## METHODS B